Literature DB >> 17664303

Rights, responsibilities and NICE: a rejoinder to Harris.

Karl Claxton1, Anthony J Culyer.   

Abstract

Harris' reply to our defence of the National Institute for Clinical Excellence's (NICE) current cost-effectiveness procedures contains two further errors. First, he wrongly draws a conclusion from the fact that NICE does not and cannot evaluate all possible uses of healthcare resources at any one time and generally cannot know which National Health Service (NHS) activities would be displaced or which groups of patients would have to forgo health benefits: the inference is that no estimate is or can be made by NICE of the benefits to be forgone. This is a non-sequitur. Second, he asserts that it is a flaw at the heart of the use of quality-adjusted life years (QALYs) as an outcome measure that comparisons between people need to be made. Such comparisons do indeed have to be made, but this is not a consequence of the choice of any particular outcome measure, be it the QALY or anything else.

Entities:  

Mesh:

Year:  2007        PMID: 17664303      PMCID: PMC2598169          DOI: 10.1136/jme.2006.018903

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  4 in total

1.  It's not NICE to discriminate.

Authors:  John Harris
Journal:  J Med Ethics       Date:  2005-07       Impact factor: 2.903

2.  Bentham in a box: technology assessment and health care allocation.

Authors:  A R Jonsen
Journal:  Law Med Health Care       Date:  1986-09

3.  Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence.

Authors:  Anthony Culyer; Christopher McCabe; Andrew Briggs; Karl Claxton; Martin Buxton; Ron Akehurst; Mark Sculpher; John Brazier
Journal:  J Health Serv Res Policy       Date:  2007-01

Review 4.  Wickedness or folly? The ethics of NICE's decisions.

Authors:  K Claxton; A J Culyer
Journal:  J Med Ethics       Date:  2006-07       Impact factor: 2.903

  4 in total
  2 in total

1.  The importance of being NICE.

Authors:  Annette Rid; Peter Littlejohns; James Wilson; Benedict Rumbold; Katharina Kieslich; Albert Weale
Journal:  J R Soc Med       Date:  2015-10-02       Impact factor: 5.344

2.  Willingness to pay for new medicines: a step towards narrowing the gap between NICE and IQWiG.

Authors:  Afschin Gandjour
Journal:  BMC Health Serv Res       Date:  2020-04-22       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.